Use of Radium-223 Dichloride in Patients With Osteonecrosis of the Jaw Induced by Zoledronic Acid: Report of 2 Cases

Saved in:
Bibliographic Details
Published in:Clinical genitourinary cancer 2019-06, Vol.17 (3), p.e612-e617
Main Authors: Dionisi, Valeria, Bellarosa, Chiara, Cardano, Raffaele, Rizzini, Elisa Lodi, Ghedini, Pietro, Morganti, Alessio Giuseppe, Fanti, Stefano, Monari, Fabio
Format: Article
Language:English
Subjects:
Aged
Bisphosphonate therapy
Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology
Bone metastases
Bone Neoplasms - drug therapy
Bone Neoplasms - secondary
Castration-resistant prostate cancer
Humans
Jaw necrosis
Male
Prostatic Neoplasms, Castration-Resistant - drug therapy
Ra-223
Radioisotopes - administration & dosage
Radioisotopes - therapeutic use
Radium - administration & dosage
Radium - therapeutic use
Treatment Outcome
Zoledronic Acid - adverse effects
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1558-7673
1938-0682
DOI:10.1016/j.clgc.2019.03.002